Research progress of implantation materials and its biological evaluation
暂无分享,去创建一个
Chen Zhao | Zeng-guo Feng | Yu Liu | Qianqian Han | Han Wang | Hang Zeng | Zhu Meng | Yong-Hao Xiao | Huan Lian | Rui-Qin Guan | Yu Liu
[1] David F. Williams. The plasticity of biocompatibility. , 2023, Biomaterials.
[2] M. A. Mirza,et al. Raw Materials, Technology, Healthcare Applications, Patent Repository and Clinical Trials on 4D Printing Technology: An Updated Review , 2022, Pharmaceutics.
[3] Jiandong Ding,et al. Recent advances in regenerative biomaterials , 2022, Regenerative biomaterials.
[4] A. Khademhosseini,et al. Recent advances in biopolymer-based hemostatic materials , 2022, Regenerative biomaterials.
[5] Vinicius M. Alves,et al. PreS/MD: Predictor of Sensitization hazard for chemical substances released from Medical Devices. , 2022, Toxicological sciences : an official journal of the Society of Toxicology.
[6] Robin Kumoluyi,et al. Risk Management in Drug-Device Combination Product Development , 2022, Therapeutic Innovation & Regulatory Science.
[7] Zixun Wang,et al. Establishing a novel 3D printing bioinks system with recombinant human collagen. , 2022, International journal of biological macromolecules.
[8] Sidra Ajmal,et al. Recent progress in development and applications of biomaterials , 2022, Materials Today: Proceedings.
[9] Jingming Gao,et al. Biomaterial-related cell microenvironment in tissue engineering and regenerative medicine , 2022, Engineering.
[10] J. A. Sánchez-Margallo,et al. Systematic Review of Tissue-Engineered Vascular Grafts , 2021, Frontiers in Bioengineering and Biotechnology.
[11] L. Teuschler,et al. Exploring the utility of the Threshold of Toxicological Concern (TTC) as a screening approach for complex substances. , 2021, Regulatory toxicology and pharmacology : RTP.
[12] Ariel A. Szklanny,et al. 3D Bioprinting of Engineered Tissue Flaps with Hierarchical Vessel Networks (VesselNet) for Direct Host‐To‐Implant Perfusion , 2021, Advanced materials.
[13] Wei Xu,et al. Regulatory perspectives of combination products , 2021, Bioactive materials.
[14] Antonios G. Mikos,et al. Machine learning and medical devices: The next step for tissue engineering , 2021, Engineering.
[15] Julie Lien Paternoster,et al. State of the art of clinical applications of Tissue Engineering in 2021. , 2021, Tissue engineering. Part B, Reviews.
[16] M. Longaker,et al. Mechanisms of bone development and repair , 2020, Nature Reviews Molecular Cell Biology.
[17] J. Pérez-Villares,et al. Promoting the ethical use of safe and effective cell-based products: the Andalusian plan on regenerative medicine , 2020, Cytotherapy.
[18] Meiyu Wu,et al. In vivo carcinogenicity study of silver nanoparticles in transgenic rasH2 mice by one single-dose intravenous administration , 2020, Journal of Nanoparticle Research.
[19] Sydney D Menikheim,et al. Self-healing biomaterials: The next generation is nano. , 2020, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[20] C. Rudge,et al. Australian regulation of autologous human cell and tissue products: implications for commercial stem cell clinics. , 2020, Regenerative medicine.
[21] S. Gad. Integrated Safety and Risk Assessment for Medical Devices and Combination Products , 2020 .
[22] Viviana Siddhi. Self-Healing , 2020, Online Journal of Complementary & Alternative Medicine.
[23] L. Ye,et al. Preparation and in vivo evaluation of surface heparinized small diameter tissue engineered vascular scaffolds of poly(ε-caprolactone) embedded with collagen suture , 2020, Journal of biomaterials applications.
[24] M. Akrami,et al. Recent progress in biomedical applications of RGD-Based ligand: From precise cancer theranostics to biomaterial engineering: A systematic review. , 2019, Journal of biomedical materials research. Part A.
[25] W. Jia,et al. Hyaluronic acid oligosaccharide-modified collagen nanofibers as vascular tissue-engineered scaffold for promoting endothelial cell proliferation. , 2019, Carbohydrate polymers.
[26] J. Ge,et al. Twelve-month angiographic and clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold and a metallic stent in patients with coronary artery disease. , 2019, International journal of cardiology.
[27] Gopal Pawar,et al. In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR , 2019, Front. Pharmacol..
[28] Gi Hoon Yang,et al. 4D Bioprinting: Technological Advances in Biofabrication. , 2019, Macromolecular bioscience.
[29] D. Tousoulis,et al. 3D Bioprinting Methods and Techniques: Applications on Artificial Blood Vessel Fabrication. , 2019, Acta Cardiologica Sinica.
[30] D. Pezzoli,et al. Heparin-Modified Collagen Gels for Controlled Release of Pleiotrophin: Potential for Vascular Applications , 2019, Front. Bioeng. Biotechnol..
[31] Liming Xu,et al. Xenogeneic bone matrix immune risk assessment using GGTA1 knockout mice , 2018, Artificial cells, nanomedicine, and biotechnology.
[32] Changyong Liu,et al. A Novel Strategy for Creating Tissue-Engineered Biomimetic Blood Vessels Using 3D Bioprinting Technology , 2018, Materials.
[33] Feng Zhao,et al. Tissue Engineering at the Blood‐Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development , 2018, Advanced healthcare materials.
[34] Tina Krenc,et al. Exploring Potential Revisions to ISO 14971 and ISO/TR 24971. , 2018, Biomedical instrumentation & technology.
[35] Takashi D Y Kozai,et al. Understanding the Inflammatory Tissue Reaction to Brain Implants To Improve Neurochemical Sensing Performance. , 2017, ACS chemical neuroscience.
[36] Chuanglong He,et al. Local Delivery of BMP-2 from Poly(lactic-co-glycolic acid) Microspheres Incorporated into Porous Nanofibrous Scaffold for Bone Tissue Regeneration. , 2017, Journal of biomedical nanotechnology.
[37] M. Khattab,et al. Novel approach to gastric mucosal defect repair using fresh amniotic membrane allograft in dogs (experimental study) , 2017, Stem Cell Research & Therapy.
[38] Yujiang Fan,et al. In vivo immunological properties research on mesenchymal stem cells based engineering cartilage by a dialyzer pocket model , 2017, Journal of Materials Science: Materials in Medicine.
[39] Zimeng Zhang,et al. 3D bioprinting of soft materials-based regenerative vascular structures and tissues , 2017 .
[40] Nikolaj Gadegaard,et al. Nacre Topography Produces Higher Crystallinity in Bone than Chemically Induced Osteogenesis. , 2017, ACS nano.
[41] H. Sakaguchi,et al. An in vitro skin sensitization assay termed EpiSensA for broad sets of chemicals including lipophilic chemicals and pre/pro-haptens. , 2017, Toxicology in vitro : an international journal published in association with BIBRA.
[42] Jenna L. Dziki,et al. Macrophage phenotype in response to ECM bioscaffolds. , 2017, Seminars in immunology.
[43] D. Gauvin,et al. The standardized functional observational battery: Its intrinsic value remains in the instrument of measure: The rat. , 2016, Journal of pharmacological and toxicological methods.
[44] B. Thomas,et al. Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice , 2016, Neuropharmacology.
[45] Sebastian Hoffmann,et al. Intra- and inter-laboratory reproducibility and accuracy of the LuSens assay: A reporter gene-cell line to detect keratinocyte activation by skin sensitizers. , 2016, Toxicology in vitro : an international journal published in association with BIBRA.
[46] T. Wynn,et al. Macrophages in Tissue Repair, Regeneration, and Fibrosis. , 2016, Immunity.
[47] Jingtian Hu,et al. Predicting carcinogenicity of organic compounds based on CPDB. , 2015, Chemosphere.
[48] Michael Glogauer,et al. Macrophages, Foreign Body Giant Cells and Their Response to Implantable Biomaterials , 2015, Materials.
[49] L. Unsworth,et al. Engineering 3D Cellularized Collagen Gels for Vascular Tissue Regeneration , 2015, Journal of visualized experiments : JoVE.
[50] Claude Auriault,et al. Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.
[51] A. Baker,et al. Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia. , 2015, ACS nano.
[52] Benjamin M Wu,et al. Recent advances in 3D printing of biomaterials , 2015, Journal of Biological Engineering.
[53] J. Teixeira,et al. Effects of iron oxide nanoparticles: Cytotoxicity, genotoxicity, developmental toxicity, and neurotoxicity , 2015, Environmental and molecular mutagenesis.
[54] Robert Landsiedel,et al. LuSens: a keratinocyte based ARE reporter gene assay for use in integrated testing strategies for skin sensitization hazard identification. , 2014, Toxicology in vitro : an international journal published in association with BIBRA.
[55] Chengtie Wu,et al. Crosslinking of saphenous vein ECM by procyanidins for small diameter blood vessel replacement. , 2014, Journal of biomedical materials research. Part B, Applied biomaterials.
[56] P. Bruegger,et al. Cryopreservation of human monocytes for pharmacopeial monocyte activation test. , 2014, Journal of immunological methods.
[57] Yujiang Fan,et al. Collagen hydrogel as an immunomodulatory scaffold in cartilage tissue engineering. , 2014, Journal of biomedical materials research. Part B, Applied biomaterials.
[58] Elliot L Chaikof,et al. Acellular vascular grafts generated from collagen and elastin analogs. , 2013, Acta biomaterialia.
[59] Gary L Bowlin,et al. Macrophage functional polarization (M1/M2) in response to varying fiber and pore dimensions of electrospun scaffolds. , 2013, Biomaterials.
[60] M. Wenk,et al. Historical Control Data of Spontaneous Tumors in Transgenic CByB6F1-Tg(HRAS)2Jic (Tg.rasH2) Mice , 2013, International journal of toxicology.
[61] C. V. van Blitterswijk,et al. Bioinformatics-based selection of a model cell type for in vitro biomaterial testing. , 2012, Biomaterials.
[62] Yuji Naito,et al. Development of tissue engineered vascular grafts and application of nanomedicine. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[63] Sumit Arora,et al. Nanotoxicology and in vitro studies: the need of the hour. , 2012, Toxicology and applied pharmacology.
[64] W. D. de Jong,et al. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. , 2011, Biomaterials.
[65] A. Piersma,et al. Comparison of the mouse Embryonic Stem cell Test, the rat Whole Embryo Culture and the Zebrafish Embryotoxicity Test as alternative methods for developmental toxicity testing of six 1,2,4-triazoles. , 2011, Toxicology and applied pharmacology.
[66] R Damoiseaux,et al. No time to lose--high throughput screening to assess nanomaterial safety. , 2011, Nanoscale.
[67] G. Gerosa,et al. First quantitative assay of alpha-Gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves. , 2011, Acta biomaterialia.
[68] William M Reichert,et al. Self-healing biomaterials. , 2011, Journal of biomedical materials research. Part A.
[69] G. Long,et al. Alternative Mouse Models for Carcinogenicity Assessment: Industry Use and Issues with Pathology Interpretation , 2010, Toxicologic pathology.
[70] Samir Mitragotri,et al. Designer Biomaterials for Nanomedicine , 2009 .
[71] Sing Yian Chew,et al. The application of nanofibrous scaffolds in neural tissue engineering. , 2009, Advanced drug delivery reviews.
[72] David F. Williams. On the nature of biomaterials. , 2009, Biomaterials.
[73] David F. Williams,et al. Different directions for the biological evaluation of biomaterials. , 2009, Medical device technology.
[74] X. Palazzi,et al. Use of rasH2 transgenic mice for carcinogenesis testing of medical implants. , 2009, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[75] R. Hamel,et al. Carbon black and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial cells: Need for multiparametric evaluation due to adsorption artifacts , 2009, Inhalation toxicology.
[76] N. Monteiro-Riviere,et al. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. , 2009, Toxicology and applied pharmacology.
[77] David F. Williams. On the mechanisms of biocompatibility. , 2008, Biomaterials.
[78] T. Bertram,et al. Tissue Engineering and Regenerative Medicine: Role of Toxicologic Pathologists for an Emerging Medical Technology , 2008, Toxicologic pathology.
[79] H. Krug,et al. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. , 2006, Nano letters.
[80] P. Tresco,et al. Response of brain tissue to chronically implanted neural electrodes , 2005, Journal of Neuroscience Methods.
[81] Liping Tang,et al. Molecular determinants of biocompatibility , 2005, Expert review of medical devices.
[82] J. O'Callaghan,et al. Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity , 2005, Expert opinion on drug safety.
[83] Sebastian Hoffmann,et al. International validation of novel pyrogen tests based on human monocytoid cells. , 2005, Journal of immunological methods.
[84] L. Schmued,et al. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons , 2005, Brain Research.
[85] Aldert H Piersma,et al. Validation of the Rat Limb Bud Micromass Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.
[86] Aldert Piersma,et al. The ECVAM International Validation Study on In Vitro Embryotoxicity Tests: Results of the Definitive Phase and Evaluation of Prediction Models , 2002, Alternatives to laboratory animals : ATLA.
[87] E Regar,et al. Stent development and local drug delivery. , 2001, British medical bulletin.
[88] M. Akashi,et al. Evaluation of biological responses to polymeric biomaterials by RT-PCR analysis IV: study of c-myc, c-fos and p53 mRNA expression. , 2000, Biomaterials.
[89] H. Tilson,et al. In vitro techniques for the assessment of neurotoxicity. , 1998, Environmental health perspectives.
[90] K. Lampe,et al. Biomaterials via Peptide Assembly: Design, Characterization, and Application in Tissue Engineering , 2021, Acta biomaterialia.
[91] Kandice M. Nappier,et al. Toxicity of Common Extractables and Leachables of Medical Devices , 2019, Integrated Safety and Risk Assessment for Medical Devices and Combination Products.
[92] Thomas Hartung,et al. From in vivo to in vitro: The medical device testing paradigm shift. , 2017, ALTEX.
[93] S. Walsh,et al. Comparing the endothelialisation of extracellular matrix bioscaffolds with coated synthetic vascular graft materials. , 2016, International journal of surgery.
[94] F. Clauss,et al. Nanostructured thick 3D nanofibrous scaffold can induce bone. , 2015, Bio-medical materials and engineering.
[95] C. Schneider,et al. The evolution of nonclinical regulatory science: advanced therapy medicinal products as a paradigm. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[96] S. Doak,et al. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. , 2009, Biomaterials.
[97] D. Farmer,et al. Assessing the predictive validity of frog embryo teratogenesis assay-Xenopus (FETAX). , 2000, Teratogenesis, carcinogenesis, and mutagenesis.
[98] M S Chapekar,et al. Tissue engineering: challenges and opportunities. , 2000, Journal of biomedical materials research.